AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 18(1), 1969, pp. 132-137
Copyright © 1969 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brody, J. A.
Right arrow Articles by Philippe, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brody, J. A.
Right arrow Articles by Philippe, Y.

Hyperreflexia and Spastic Paralysis Among New Caledonian Leprosy Patients

Jacob A. Brody*, Yoshiro Yase{dagger}, Gerard Chemier AND Yves Philippe
L'Institut-Pasteur and l'Hôpital Gaston Bourret, Noumea, New Caledonia

A survey on New Caledonia confirmed the occurrence of a previously reported syndrome of spastic paralysis among leprosy patients. Of 18 patients recorded as having frank spastic paraplegia, seven were examined neurologically, as well as 51 other patients with leprosy but not spastic paralysis, and 23 patients with tuberculosis. Significant hyperreflexia was fairly common among both Melanesian and European leprosy patients, but was totally absent among tuberculosis patients. This syndrome was clinically unrelated to foci of neurologic disease previously reported in the Pacific Basin on Guam, the Kii Peninsula of Japan, and New Guinea. It is probably more closely related to diseases reported in other parts of the world that are generally regarded as nutritional or toxic in origin. The syndrome is possibly related to sulfone treatment of leprosy, although this has not been reported in other areas of the world where sulfones are used in the treatment of leprosy.


* Epidemiology Branch, C&FR, National Institute of Neurological Diseases and Blindness, National Institutes of Health, Bethesda, Maryland 20014.


{dagger} Division of Neurological Diseases, Wakayama Medical College, Wakayama-Shi, Japan.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American Society of Tropical Medicine and Hygiene.